Moneycontrol PRO

Bajaj Healthcare: Off-colour Q1 no spoilsport for the long run

Capacity ramp-up and new business opportunities should stand Bajaj Healthcare in good stead; any correction a scope to buy

September 08, 2022 / 04:32 PM IST
Bajaj Healthcare: Off-colour Q1 no spoilsport for the long run

Representative image

PRO Only Highlights
Quarterly performance largely backed by improved realisations
Medium-term triggers China plus and protectionist measures for tyre industry
Valuations not inexpensive; but improved medium-term outlook

Bulk drug manufacturer Bajaj Healthcare (BHL) reported a lacklustre set of numbers for Q1 FY23. While the company saw a moderate decline in revenues, operating margins stabilised on a sequential basis (quarter-on-quarter). Result snapshot In Q1, BHL’s revenues declined 8 percent year on year (YoY) to Rs 172 crore primarily due to the contraction of Covid-19 related opportunities.  Operating margins continued to suffer on account of adverse changes in the product mix, normalisation of prices after the initial COVID spike, and...

  • PRO Panorama

    Moneycontrol Pro Panorama | Sensex gets a global crown

    Nov 25, 2022 / 03:17 PM IST

    In today’s edition of Moneycontrol Pro Panorama: Green energy stocks fail to impress investors, online gaming under pressure, sluggish phase in equities expected, and more

    Read Now
  • PRO Weekender

    Moneycontrol Pro Weekender | Outrunning the bear

    Nov 5, 2022 / 01:07 PM IST

    As the economies try their best to ward off a hard landing, India comes out as an outlier. It’s a classic case of just staying the course amid difficult times

    Read Now

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers